J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
The Journal of Clinical Pharmacology, 1974; 14:325-328
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Du Souich, P.
Right arrow Articles by Garcia-Sevilla, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Du Souich, P.
Right arrow Articles by Garcia-Sevilla, J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Pharmaceutical Specialties in the U.S.— A Note About the PDR 1972

Patricio Du Souich M.D.1, Sergio Erill M.D.1, and Jesus A. Garcia-Sevilla M.D.1

1 Departamento de Ciencias Fisiológicas, Universidad Autónoma de Barcelona, Barcelona, Spain.

This survey was done in order to exploit the possibilities of a widely used compendium, the Physicians" Desk Reference, as a source of information concerning prevalence of fixed-ratio drug combinations (FRC) among prescription drugs in the U.S. Less than half of the products presented in the PDR 1972 were found to be single drug compounds while, at the other end of the spectrum, more than 7 per cent contained more than eight active ingredients. Drug companies showed quite different patterns with regards to marketing of FRC. Fixed-ratio drug combinations accounted for less than 10 per cent of the products offered by 26 companies, while 69 drug firms included between 90 and 100 per cent of FRC in their products listed in the PDR.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American College of Clinical Pharmacology